Peptide protocol for Elisa

1 min read · July 3, 2026 · skyfireusa

Based on current research trends and common practices in regenerative medicine circles, here is a conservative overview:

Compound

Common Research/Clinic Range

Typical Frequency

Comments

NAD+

100–300 mg/day (SC or IM) or 250–500 mg 1–3×/week

3–7 days/week

Many users start low because higher doses can cause nausea or flushing.

Retatrutide

0.5–2 mg/week initially

Once weekly

Dose is typically increased slowly over months due to GI side effects.

MOTS-c

5–15 mg

2–3 days/week

Often used in intermittent cycles rather than daily.

GHK-Cu

1–2 mg/day

5–7 days/week

Used by some for skin, healing, or hair protocols; evidence in healthy humans remains limited.

[Likely] NAD+

A reasonable conservative regimen would be 100–200 mg per day, 5 days per week.
Some clinics instead administer 250–500 mg once or twice weekly.
More is not necessarily better; benefits above moderate doses are unproven.

[Likely] Retatrutide

Since she is 120 lb with an estimated ideal weight around 108 lb, she only has about 12 lb she might wish to lose.
I would not recommend aggressive dosing.
If she and her physician decide to use it, many protocols start at 0.5 mg once weekly, increasing only if needed and tolerated.
If weight loss is the sole goal, lifestyle changes may achieve it without medication.

[Likely] MOTS-c

A common protocol is 5 mg injected 2–3 times per week.
Some users employ 10 mg three times weekly in cycles lasting several weeks followed by time off.

[Likely] GHK-Cu

A conservative research-oriented dose is 1 mg daily, with some protocols using up to 2 mg daily.
Typical cycles range from 4–8 weeks, followed by reassessment.

Important considerations

[Certain] Elisa’s allergy to ciprofloxacin does not imply an allergy to NAD+, Retatrutide, MOTS-c, or GHK-Cu.